Prodromal frontotemporal dementia: clinical features and predictors of progression

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1758-9193
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Prodromal frontotemporal dementia: clinical features and predictors of progression ; volume:13 ; number:1 ; day:15 ; month:11 ; year:2021 ; pages:1-10 ; date:12.2021
Alzheimer's research & therapy ; 13, Heft 1 (15.11.2021), 1-10, 12.2021

Urheber
Benussi, Alberto
Ashton, Nicholas J.
Karikari, Thomas K.
Alberici, Antonella
Saraceno, Claudia
Ghidoni, Roberta
Benussi, Luisa
Zetterberg, Henrik
Blennow, Kaj
Borroni, Barbara
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s13195-021-00932-2
URN
urn:nbn:de:101:1-2022012522062028585208
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:24 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Benussi, Alberto
  • Ashton, Nicholas J.
  • Karikari, Thomas K.
  • Alberici, Antonella
  • Saraceno, Claudia
  • Ghidoni, Roberta
  • Benussi, Luisa
  • Zetterberg, Henrik
  • Blennow, Kaj
  • Borroni, Barbara
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Sex influences clinical phenotype in frontotemporal dementia

Sex influences clinical phenotype in frontotemporal dementia

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

Fluid biomarkers in Alzheimer’s disease – current concepts

Fluid biomarkers in Alzheimer’s disease – current concepts

Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease

Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease

Repeated lumbar punctures within 3 days may affect CSF biomarker levels

Repeated lumbar punctures within 3 days may affect CSF biomarker levels

BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease

BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease

Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study

Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study

Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data

Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data

Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus

Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus

Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s disease

Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s disease

Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias

Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias

Verbundene Objekte